Acute Kidney Injury in Stem Cell Transplant Recipients

  • Daniella Levy-Erez
  • Sangeeta Hingorani
  • Benjamin LaskinEmail author


Hematopoietic cell transplantation treats life-threatening disorders in children but is associated with very high rates of morbidity affecting multiple organ systems. The kidney is commonly affected in children who have received a hematopoietic cell transplant. The causes of acute kidney injury among this population are most likely multifactorial and depend on the timing of kidney injury in relation to the transplant. Patients undergoing hematopoietic cell transplant are exposed to multiple potential nephrotoxins including chemotherapy and radiation used for conditioning, antimicrobials to prevent or treat infections, and calcineurin inhibitors and other medications to prevent or treat graft-versus-host disease. Additional causes of acute kidney injury include sepsis leading to hemodynamic instability and the resulting acute tubular necrosis. Endothelial injury causing sinusoidal obstruction syndrome or thrombotic microangiopathy and graft-versus-host disease itself are other significant mechanisms for acute kidney injury after hematopoietic cell transplant. While targeted therapies for acute kidney injury are limited, management includes management of fluid and electrolyte balance and the correct dosing of medications. Severe volume overload may necessitate renal replacement therapy, which has been associated with high mortality rates after hematopoietic cell transplant. This chapter reviews the most current data on the risk of acute kidney injury in children after hematopoietic cell transplant, the presumed causes, and the approach to diagnosing and managing these complex patients.


Hematopoietic cell transplantation Acute kidney injury Thrombotic microangiopathy Sinusoidal obstruction syndrome Graft-versus-host disease 


  1. 1.
    Didsbury MS, Mackie FE, Kennedy SE. A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients. Pediatr Transplant. 2015;19(5):460–70.CrossRefPubMedGoogle Scholar
  2. 2.
    DiCarlo J, Alexander SR. Acute kidney injury in pediatric stem cell transplant recipients. Semin Nephrol. 2008;28(5):481–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Hingorani S. Renal complications of hematopoietic-cell transplantation. N Engl J Med. 2016;374(23):2256–67.CrossRefPubMedGoogle Scholar
  4. 4.
    Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091–101.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant. 2010;25(1):278–82.CrossRefPubMedGoogle Scholar
  6. 6.
    Lopes JA, Jorge S, Neves M. Acute kidney injury in HCT: an update. Bone Marrow Transplant. 2016;51(6):755–62.CrossRefPubMedGoogle Scholar
  7. 7.
    Lopes JA, Jorge S, Silva S, de Almeida E, Abreu F, Martins C, et al. Acute renal failure following myeloablative autologous and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2006;38(10):707.CrossRefPubMedGoogle Scholar
  8. 8.
    Krishnappa V, Gupta M, Manu G, Kwatra S, Owusu OT, Raina R. Acute kidney injury in hematopoietic stem cell transplantation: a review. Int J Nephrol. 2016;2016:5163789.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Raina R, Herrera N, Krishnappa V, Sethi SK, Deep A, Kao WM, Bunchman T, Abu-Arja R. Hematopoietic stem cell transplantation and acute kidney injury in children: a comprehensive review. Pediatr Nephrol. 2017;21(4):e12935.Google Scholar
  10. 10.
    Hingorani SR, Guthrie K, Batchelder A, Schoch G, Aboulhosn N, Manchion J, et al. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int. 2005;67(1):272–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol. 2009;4(2):345–53.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, et al. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transfus Apher Sci. 2016;54(2):181–90.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Flores FX, Brophy PD, Symons JM, Fortenberry JD, Chua AN, Alexander SR, et al. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT registry group. Pediatr Nephrol. 2008;23(4):625–30.CrossRefGoogle Scholar
  14. 14.
    Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol. 2007;2(4):732–8.CrossRefGoogle Scholar
  15. 15.
    Michael M, Kuehnle I, Goldstein SL. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol. 2004;19(1):91–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Kersting S, Dorp SV, Theobald M, Verdonck LF. Acute renal failure after nonmyeloablative stem cell transplantation in adults. Biol Blood Marrow Transplant. 2008;14(1):125–31.CrossRefPubMedGoogle Scholar
  17. 17.
    Rajpal JS, Patel N, Vogel RI, Kashtan CE, Smith AR. Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013;19(4):661–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Kizilbash SJ, Kashtan CE, Chavers BM, Cao Q, Smith AR. Acute kidney injury and the risk of mortality in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016;22(7):1264–70.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Keddis M, Leung N, Herrmann S, El-Zoghby Z, Sethi S. Adenovirus-induced interstitial nephritis following umbilical cord blood transplant for chronic lymphocytic leukemia. Am J Kidney Dis. 2012;59(6):886–90.CrossRefPubMedGoogle Scholar
  20. 20.
    Liu KD, Thompson BT, Ancukiewicz M, Steingrub JS, Douglas IS, Matthay MA, et al. Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med. 2011;39(12):2665–71.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Laskin BL, Nehus E, Goebel J, Furth S, Davies SM, Jodele S. Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014;20(12):2056–61.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Chapman T, Bodmer N, Benkeser DC, Hingorani SR, Parisi MT. Transient renal enlargement in pediatric hematopoietic cell transplant recipients. Pediatr Transplant. 2014;18(3):288–93.CrossRefPubMedGoogle Scholar
  23. 23.
    Bajwa RPS, Mahadeo KM, Taragin BH, Dvorak CC, McArthur J, Jeyapalan A, et al. Consensus report by pediatric acute lung injury and Sepsis investigators and pediatric blood and marrow transplantation consortium joint working committees: supportive care guidelines for Management of Veno-Occlusive Disease in children and adolescents, part 1: focus on investigations, prophylaxis, and specific treatment. Biol Blood Marrow Transplant. 2017;23(11):1817–25.CrossRefPubMedGoogle Scholar
  24. 24.
    Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118(6):1452–62.CrossRefPubMedGoogle Scholar
  25. 25.
    Laskin BL, Goebel J, Davies SM, Khoury JC, Bleesing JJ, Mehta PA, et al. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT. Bone Marrow Transplant. 2011;46(5):682–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Cordero C, Loboda C, Clerc-Urmes I, Clement L, Pochon C, Chastagner P. Unexpected acute renal injury after high-dose etoposide phosphate and total body irradiation in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2017;64(12):e26669. Epub 2017 Jul 11CrossRefGoogle Scholar
  27. 27.
    Caruso Brown AE, Cohen MN, Tong S, Braverman RS, Rooney JF, Giller R, et al. Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. Antimicrob Agents Chemother. 2015;59(7):3718–25.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550–61.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Haines HL, Laskin BL, Goebel J, Davies SM, Yin HJ, Lawrence J, et al. Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(10):1512–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Sanchez-Pinto LN, Laskin BL, Jodele S, Hummel TR, Yin HJ, Goebel J. BK virus nephropathy in a pediatric autologous stem-cell transplant recipient. Pediatr Blood Cancer. 2011;56(3):495–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Parmar V, Lewis M, Shenoy M, Bonney D, Wynn R. Ascitic fluid drainage using a peritoneal dialysis catheter to prevent and treat multi-organ dysfunction in veno-occlusive disease in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2017;64(9):e26469.CrossRefGoogle Scholar
  32. 32.
    Corbacioglu S, Richardson PG. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation. Expert Rev Gastroenterol Hepatol. 2017;11(10):885–98.CrossRefPubMedGoogle Scholar
  33. 33.
    Gloude NJ, Jodele S, Teusink-Cross A, Grimley M, Davies SM, Lane A, et al. Combination of high-dose methylprednisolone and defibrotide for veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2018;24(1):91–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015;29(3):191–204.CrossRefPubMedGoogle Scholar
  35. 35.
    Abusin GA, Abu-Arja R, Bajwa RPS, Horwitz EM, Auletta JJ, Rangarajan HG. Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies. Pediatr Blood Cancer. 2017;64:9. Epub 2017 Mar 23CrossRefGoogle Scholar
  36. 36.
    Jodele S, Licht C, Goebel J, Dixon BP, Zhang K, Sivakumaran TA, et al. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood. 2013;122(12):2003–7.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Laskin BL, Maisel J, Goebel J, Yin HJ, Luo G, Khoury JC, et al. Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transplantation. 2013;96(2):217–23.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Jodele S, Zhang K, Zou F, Laskin B, Dandoy CE, Myers KC, et al. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood. 2016;127(8):989–96.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Hingorani SR, Seidel K, Pao E, Lawler R, McDonald GB. Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantation. Bone Marrow Transplant. 2015;50(5):715–20.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood. 2014;124(4):645–53.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Bohl SR, Kuchenbauer F, von Harsdorf S, Kloevekorn N, Schonsteiner SS, Rouhi A, et al. Thrombotic microangiopathy after allogeneic stem cell transplantation: a comparison of eculizumab therapy and conventional therapy. Biol Blood Marrow Transplant. 2017;23(12):2172–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Gloude NJ, Khandelwal P, Luebbering N, Lounder DT, Jodele S, Alder MN, et al. Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD. Blood. 2017;130(10):1259–66.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Hingorani S, Finn LS, Pao E, Lawler R, Schoch G, McDonald GB, et al. Urinary elafin and kidney injury in hematopoietic cell transplant recipients. Clin J Am Soc Nephrol. 2015;10(1):12–20.CrossRefPubMedGoogle Scholar
  44. 44.
    Hingorani SR, Seidel K, Lindner A, Aneja T, Schoch G, McDonald G. Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. Biol Blood Marrow Transplant. 2008;14(12):1365–72.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Hingorani S, Gooley T, Pao E, Sandmaier B, McDonald G. Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease. Bone Marrow Transplant. 2014;49(3):403–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Chien YH, Lin KH, Lee TY, Lu MY, Tsau YK. Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease. J Formos Med Assoc. 2000;99(6):503–6.PubMedGoogle Scholar
  47. 47.
    Motoyama O, Takasu J, Kawamura T, Aikawa A, Shigetomi Y, Nara C, et al. A male patient with malignant lymphoma and thyroid papillary carcinoma after pediatric renal transplantation. Clin Exp Nephrol. 2010;14(1):94–6.CrossRefPubMedGoogle Scholar
  48. 48.
    Walker JV, Morich D, Anasetti C. Minimal-change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am J Kidney Dis. 1995;26(3):532–4.CrossRefPubMedGoogle Scholar
  49. 49.
    Montaruli E, Wildhaber BE, Ansari M, Birraux J. Adenovirus-induced obstructive uropathy with acute renal failure in an immunodeficient child. Urology. 2014;83(1):217–9.CrossRefPubMedGoogle Scholar
  50. 50.
    Haab AC, Keller IS, Padevit C, John H. BK virus associated pronounced hemorrhagic cystoureteritis after bone marrow transplantation. Can J Urol. 2015;22(5):8009–11.PubMedGoogle Scholar
  51. 51.
    Oshrine B, Bunin N, Li Y, Furth S, Laskin BL. Kidney and bladder outcomes in children with hemorrhagic cystitis and BK virus infection after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(12):1702–7.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB, et al. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int. 2016;90(1):212–21.CrossRefPubMedGoogle Scholar
  53. 53.
    Zinter MS, Dvorak CC, Spicer A, Cowan MJ, Sapru A. New insights into multicenter PICU mortality among pediatric hematopoietic stem cell transplant patients. Crit Care Med. 2015;43(9):1986–94.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Chima RS, Daniels RC, Kim MO, Li D, Wheeler DS, Davies SM, et al. Improved outcomes for stem cell transplant recipients requiring pediatric intensive care. Pediatr Crit Care Med. 2012;13(6):e336–42.CrossRefPubMedGoogle Scholar
  55. 55.
    Basu RK, Zappitelli M, Brunner L, Wang Y, Wong HR, Chawla LS, et al. Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. 2014;85(3):659–67.CrossRefPubMedGoogle Scholar
  56. 56.
    Kinsey GR, Sharma R, Okusa MD. Regulatory T cells in AKI. J Am Soc Nephrol. 2013;24(11):1720–6.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol. 2006;17(7):1995–2005.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Daniella Levy-Erez
    • 1
  • Sangeeta Hingorani
    • 2
  • Benjamin Laskin
    • 1
    Email author
  1. 1.Division of NephrologyThe Children’s Hospital of PhiladelphiaPhiladelphiaUSA
  2. 2.Division of NephrologySeattle Children’s HospitalSeattleUSA

Personalised recommendations